- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04342871
An Evaluation of the Families Addressing Cancer Together (FACT) Intervention (FACT)
March 3, 2024 updated by: UNC Lineberger Comprehensive Cancer Center
A Pilot Study Evaluating the Feasibility, Acceptability, and Preliminary Evidence of Efficacy of the Families Addressing Cancer Together (FACT) Intervention
This is a pilot feasibility and acceptability study to inform the development and testing of a novel communication intervention to support parents in their communication with children about cancer.
The research questions to be answered by this study are whether the intervention being tested can be feasible and acceptable, and provide preliminary estimates of improvement in parental psychological distress.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a single-arm, single center pilot study using a pretest-posttest design to evaluate the feasibility and acceptability of a psychosocial intervention, Families Addressing Cancer Together (FACT).
The purpose of the intervention is to decrease parental anxiety by facilitating parental communication about cancer with their children.
The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible, acceptable, and reduce parental psychological distress.
Findings from this study will inform a future grant application to further test this intervention in a randomized controlled trial.
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Informed consent reviewed and signed;
- Age equal to or above 18 years;
- Ability to understand and comply with study procedures;
- Be a parent, primary caregiver, or guardian of at least one child between the ages of 3-19 years old with whom the subject has regular contact. The child must have cognitive ability to understand verbal communication;
- Have a new or recurrent diagnosis of invasive solid tumor malignancy within the past 6 months or have a solid tumor cancer diagnosis with disease that is either stage IV or equivalent;
- Have a cancer diagnosis that is likely to require systemic anti-neoplastic therapy, non-office based surgical intervention, radiation therapy, or palliative care/hospice within the next three months.
Exclusion Criteria:
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FACT
Patients will receive access to intervention materials.
|
Customized communication guidance to help parents with cancer talk about their cancer with their children.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form FACT Was Helpful
Time Frame: 14 days
|
Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, "Families Addressing Cancer Together (FACT) satisfaction scale."
Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
|
14 days
|
|
Acceptability of the Intervention Assessed Via Semi-structured Interviews
Time Frame: 14 days
|
Participants were interviewed about their experiences with the study intervention using semi-structured interviews.
Parents' comments on the intervention "helped them feel more comfortable and prepared to talk with their children about their illness" were graded as participants overall intervention satisfaction.
|
14 days
|
|
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form-FACT Was Useful
Time Frame: 14 days
|
Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, "Families Addressing Cancer Together (FACT) satisfaction scale."
Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
|
14 days
|
|
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form Content Was Important
Time Frame: 14 days
|
Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, "Families Addressing Cancer Together (FACT) satisfaction scale."
Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
|
14 days
|
|
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form- Overall Satisfaction
Time Frame: 14 days
|
Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, "Families Addressing Cancer Together (FACT) satisfaction scale."
Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Screening
Time Frame: Baseline
|
The number of subjects who were screened, recruited, and retained in the study were reported.
|
Baseline
|
|
Feasibility of Recruitment
Time Frame: Baseline
|
Number of patients who enroll in the study
|
Baseline
|
|
Communication Self-efficacy Measured by the Adapted Communication Self-Efficacy Scale
Time Frame: Baseline, 14 days, 84 days
|
Assess the change in patient's communication self-efficacy.
The adapted Communication Self-Efficacy scale is a 9-item Visual Analogue Scale assessing parent's confidence in their ability to tell their child about parental medical illness.
The score range is 0 to 100 with higher scores indicating higher confidence.
|
Baseline, 14 days, 84 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Eliza Park, MD, University of North Carolina, Chapel Hill
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 5, 2020
Primary Completion (Actual)
July 27, 2021
Study Completion (Actual)
July 27, 2021
Study Registration Dates
First Submitted
March 29, 2020
First Submitted That Met QC Criteria
April 8, 2020
First Posted (Actual)
April 13, 2020
Study Record Updates
Last Update Posted (Actual)
August 15, 2024
Last Update Submitted That Met QC Criteria
March 3, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- LCCC2030
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Neoplasms | Colon Neoplasms | Metagenome | MicrobiotaChina
-
European Association for Endoscopic SurgeryWithdrawn
-
Moscow Clinical Scientific CenterRecruitingCecal Neoplasms | Colonic Neoplasms MalignantRussian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruitingPeritoneal CarcinomatosisUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingColonic NeoplasmsChina
-
Nanjing Medical UniversityNot yet recruitingMalignant Meningioma
-
Joshua PalmerRayzeBio, Inc.RecruitingRecurrent MeningiomaUnited States
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRegeneron PharmaceuticalsNot yet recruiting
-
Royal North Shore HospitalNorthern Sydney and Central Coast Area Health ServiceRecruiting
Clinical Trials on FACT
-
Northwestern UniversityNational Institute on Aging (NIA)CompletedInfluenza VaccinationUnited States
-
Istituto Auxologico ItalianoRecruiting
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institute of Allergy and Infectious...CompletedNeoplasms | Cancer | Communication | Parent-Child Relations | Parenting | ParentsUnited States
-
Children's Mercy Hospital Kansas CityNational Institute of Mental Health (NIMH)Recruiting
-
University of TorontoThe Hospital for Sick ChildrenCompletedMothers of Newborn InfantsCanada
-
University of Wisconsin, MadisonRecruitingOvarian Cancer | Cognitive ChangeUnited States
-
Karl Landsteiner Institute for Lung Research and...Completed
-
New York UniversityCompleted
-
Universita degli Studi di GenovaRecruiting
-
University of Maryland, College ParkCompleted